A detailed history of Abound Wealth Management transactions in Grifols Sa stock. As of the latest transaction made, Abound Wealth Management holds 21 shares of GRFS stock, worth $164. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21
Previous 26 19.23%
Holding current value
$164
Previous $164,000 14.02%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$6.28 - $9.38 $31 - $46
-5 Reduced 19.23%
21 $187,000
Q1 2024

Aug 08, 2024

BUY
$5.47 - $11.38 $142 - $295
26 New
26 $174,000

Others Institutions Holding GRFS

About Grifols SA


  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $5.33B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track This Portfolio

Track Abound Wealth Management Portfolio

Follow Abound Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Abound Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Abound Wealth Management with notifications on news.